SlideShare une entreprise Scribd logo
1  sur  54
Dr.shenawi 
Cons. general surgery 
M.g.h 
MBBCh,MsC,MrCs(irelanD)
 I,m not an intensivist &apologize for deficiency it 
might encountered on the mini lecture. 
 Thanks& greeting to all my colleagues& staff in 
MGH,for their sympathy and support given to me 
during my assignment in hajj duty. 
 Accept my appology for any missbehave might 
happen from me during my duty. 
Dr.abdulfattah alshenawi
 It’s common and increasing in frequency as the 
population ages 
 It’s associated with high risk of death and long 
length of stay 
We could make a 
 It’s expensive 
difference 
 AND…. The good new is: 
 There are interventions proven to reduce 
mortality & cost. 
 However implementation of these interventions 
are not routinely done in all hospitals!!
 35% diagnosed in hospital wards. 
 52% diagnosed in ED. 
 13 % diagnosed in ICU. 
 Hospitalization for sepsis & sepsis related 
illness has doubled in the states from year 
2000 -2008.
 Sever sepsis & septic shock is the leading 
cause of death in the non coronary care 
with mortality rate of 20 -50%. 
Ischemic stroke 1-2% 
STEMI 3-5%
Cost 14-18 billion USD /y. 
Cost 18.000 USD/case.
 Inflammation is a war! 
 Non specific localized tissue response to injury. 
 Purpose: 
◦ Destroy 
◦ Dilute 
◦ Dam-off 
 result is healing 
◦ Regeneration (hyperplasia) 
◦ Fibrosis (scarring) 
 Collateral damage may occur(SIRS)
 1. Stimulus: Initiators of inflammation 
 2. Local dilation of capillaries: increased blood 
flow 
 3. Microvascular structural changes: escape of 
 plasma proteins from bloodstream 
 4. Leukocyte transmigration through 
endothelium 
 and accumulation at injury site 
 5. Phagocytosis / Oxygen burst: Cellular injury
 Leucocytic response.(organism specific) 
 Margination&migration of neutrophils(90min) 
 Phagocytosis .(physiologic debridment) 
 Monocyte migration(24hrs)-macrophage. 
 Release of cytokines.
Definition: Any messenger that acts on blood vessels, 
inflammatory cells, or other cells to contribute to an 
inflammatory response. (Pretty much anything...)
 Plasma proteins such as complement and 
antibodies. 
 Other proteins such as sPLA2 and acute phase 
reactants. 
 Cytokines and chemokines. 
 Lipids such as prostaglandins and PAF. 
 Amines such as histamine. 
 ‘Gasses’ such as NO and O2-. 
 Kinins such as bradykinin. 
 Neuropeptides such as substance P.
 Systemic absorption of locally generated 
inflamatory mediators. 
 Non specific response!!! 
 May be due to infectious or non infectious causes.
 Fever>100 
 pulse.>100 
 SBP<100 
 leucocytosis 
 RR>20 
May be caused by infections(sepsis) 
 Altered mental status 
 Hyperglycemia 
 or non 
infections(burn,trauma,pancreatitis, 
ischemia,reperfusion,chemical)
SIRS 
SEPSIS 
SEVER SEPSIS 
SEPTIC SHOCK
SIRS+INFECTION(kn 
own or suspected) 
Infection may be 
bacterial,viral ,fungal … 
etc.
TRAUMA 
BURNS 
INFECTION SSEEPPSSIISS SIRS 
PANCREAITIS 
BACTEREMIA
SSEEPPSSIISS++22OORRGGAANN 
ddyyssffuunnccttiioonn
 SEVER SEPSIS+ REFRACTORY 
HYPOTENSION
 Normal response to infection. 
Recognition of foreign antigen. 
Immune system release inflammatory 
mediators(PG,TNF,cytokines,interleuk) 
Platlet activating factors. 
Promote recovery of the affected 
tissues.
 Uncontrolled response to 
infection(sepsis syn) 
 Flood of inflammatory mediators 
Capillary leak. 
 Activation of clotting cascade. 
 Tissue hypoxia & hypoperfusion. 
 Septic shock. 
Microcirculatory failure is the key!!!
Figure B, page 948, reproduced with permission from Dellinger RP. Cardiovascular 
management of septic shock. Crit Care Med 2003;31:946-955.
 Site of oxygen exchange. 
Central role of the immune system. 
During septic shock,it the first to go & late 
to recover. 
Rescue microcirculation is the 
resuscitation end point.
Infection 
Inflammatory 
Mediators 
Endothelial 
Vasodilation Dysfunction 
Hypotension Microvascular Plugging 
Vasoconstriction Edema 
Maldistribution of Microvascular Blood Flow 
Ischemia 
Cell Death 
Organ Dysfunction
Oxygen won,t go where 
blood don,t flow. 
Early goal directed 
therapy(EGDT) IS to restore 
microcirculation before 
mitochondia is permenantly 
damaged.
Acute organ dysfunction is 
the marker of sever sepsis. 
One organ damage lead to 
20% increase mortality& 
double thereafter.
A clinician, armed with the sepsis bundles, 
attacks the three heads of severe sepsis: 
hypotension, hypoperfusion and organ 
dysfunction 
.
 Recognition& screening for sepsis. 
 ivf 
 Early antibiotics. 
 Transfer trigger tool. 
 Emergency dept. initiation of 6hs bundle.
 Non specific symptoms in elderly pt. 
 Fever may be absent.13% in pt>65y& 4% in 
pt<65y 
 Tachycardia may be absent. 
 Presentation may be of M.O.D initially.
Pt. presented with. 
Weakness 
Confusion 
Vomiting 
Syncope 
early recognition of sepsis & 
implementation of evidence based tools 
improves outcome & reduce mortality.
 Sepsis screening tools should be 
practiced in all hospitals& 
wards(ER,ICU,& GENERAL WARDS)
2 or more of the following 
 Temp>100 F 
 Pulse>100/min 
 SBP<100mmHg. 
RR>20/min 
 Spo2<90% 
 Altered LOC
 Initiate evaluation for sever sepsis & 
septic shock. 
 Order S. lactate(result within 30min) 
 Order CBC,ABG,U/cr/E,& metabolic 
profile. 
 Attach monitors. 
 Start IVF & antibiotics. 
 Notify consultant.
 Lactate is a surrogate marker of global tissue 
hypoxia. 
 Normal is<2mmol/l 
 More >4mmol/l indicate tissue hypoperfusion 
 Lactate elevation above normal associated with 
increased mortality. 
 Marker of (OCCULT )sepsis before 
hypoperfusion or altered LOC happen.
 Arterial or venous, no tourniquet 
 Normal lactate do not rule out severe 
sepsis. 
 Lactate may be elevated with seizures, 
liver cell failure, ischemic bowels,& 
drugs
 Decrease by> 10% every hour. 
 Normalisation within 6 hs. 
Associated with reduced mortality. 
 Half life of lactate is 20 min.
20 -30 ml /kg initial fluid 
bolus. 
Minimum 1 L bolus. 
Minimum of 30ml/kg in the first 
3hrs.
 Each 1 h delay in effective antibiotics is 
associated with decrease in survival by 
7.6%. 
 Triage time to appropriate 
antibiotics<1hr 
_____mortality 19.5 vs 32.2%
Don,t let a prolonged search for the 
source delay antibiotic administration. 
Brief search &best guess ABX. 
consider blood culture & empiric 
antibiotics pending further evaluation 
Stop antibiotics when no longer needed.
 Follow your own hospital protocol. 
 Pipracillin / tazocin. 4.5gm/6h.+ 
 Vancomycin 2gm iv stat then adjust 
according to pharmacy. 
 Penicillin allergy 
 meropenem 1gm iv/8h 
 Community acquired pneumonia 
 Levofloxacin 750mg iv/24h 
 Azithromycin 500mgiv/24h
 For hospital without ICU. any of the 
following 
PROGRESSIVE SYMPTOMS DESPITE 
TREATMENT 
PERSISTENT ELEVATED LACT.>4mmol/l 
PERSISTENT HYPOTENSION DESPITE 
FLUID CHALLENGE 
MORE THAN TWO ORGAN 
DYSFUNCTION
 To be completed within 3 hs!! 
Measure lactate. 
Bl. Culture prior to antibiotics. 
Antibiotics. 
 Infusion of 30ml/kg crystalloids in 
hypotension or lactate >4mmol/l
 Apply vasopressors for those not 
responding to fluid challenge to maintain 
MAP>65 mmhg. 
 Persistent hypotension despit fluids, 
measure 
CVP 
ScvO2 
 Re measure lactate if initially elevated.
1. CVP of 10mmhg for 
unventilated &12-15 mmhg for 
the ventilated 
2. MAP >65mmhg 
3. Hemoglobin > 9 gm/dL 
4. ScvO2 > 70% 
5. UOP>0.5ml/h
3 hs bundle 
 (culture, crystalloid, lactate,& 
antibiotic.) 
6 hs bundle 
Continue resuscitation 
Cvp,monitor,follow lactate. 
Consider inotropes
 Screen pt . For sepsis. In ED 
&wards. 
 Evaluate all pt. with sepsis for 
organ dysfunction to identify sever 
sepsis. 
 Implement sepsis bundles for all 
pts with sever sepsis & septic 
shock.
 Obtain lactate when 2 SIRS or suspected 
infection. 
 Begin 3hrs bundle when screen is +ve. 
 For ED pt. u have 3 hrs from arrival to 
determine pt has an infection, find the 
likely source,& begin the appropriate 
therapy. 
 Clock is not your friend!
Sepsis nuts&bolts
Sepsis nuts&bolts

Contenu connexe

Tendances

Hemolytic transfusion reaction
Hemolytic transfusion reactionHemolytic transfusion reaction
Hemolytic transfusion reaction
Shreyas Kate
 
Hemodialysis Final
Hemodialysis FinalHemodialysis Final
Hemodialysis Final
sakurayel
 
Lethal triad case study no questions
Lethal triad case study no questionsLethal triad case study no questions
Lethal triad case study no questions
Chloe Buechler
 

Tendances (20)

Heparin and dialysis – hhd and pd
Heparin and dialysis – hhd and pdHeparin and dialysis – hhd and pd
Heparin and dialysis – hhd and pd
 
Acute complications of haemodialysis
Acute complications of haemodialysisAcute complications of haemodialysis
Acute complications of haemodialysis
 
Sepsis and septic shock guidelines
Sepsis  and septic shock guidelinesSepsis  and septic shock guidelines
Sepsis and septic shock guidelines
 
Bleeding Disorders: Classification and Diagnosis
Bleeding Disorders: Classification and DiagnosisBleeding Disorders: Classification and Diagnosis
Bleeding Disorders: Classification and Diagnosis
 
Dialysis disequilibrium-syndrome
Dialysis disequilibrium-syndromeDialysis disequilibrium-syndrome
Dialysis disequilibrium-syndrome
 
Haemodialysis complications
Haemodialysis complicationsHaemodialysis complications
Haemodialysis complications
 
Specific organ support in icu
Specific organ support in icuSpecific organ support in icu
Specific organ support in icu
 
Trauma lethal triad
Trauma lethal triadTrauma lethal triad
Trauma lethal triad
 
Spotlight on indication of dialysis
Spotlight on indication of dialysisSpotlight on indication of dialysis
Spotlight on indication of dialysis
 
Hemolytic transfusion reaction
Hemolytic transfusion reactionHemolytic transfusion reaction
Hemolytic transfusion reaction
 
Shock
ShockShock
Shock
 
Hemodialysis Final
Hemodialysis FinalHemodialysis Final
Hemodialysis Final
 
Lethal triad case study no questions
Lethal triad case study no questionsLethal triad case study no questions
Lethal triad case study no questions
 
Complications of massive blood transfusion
Complications of massive blood transfusionComplications of massive blood transfusion
Complications of massive blood transfusion
 
Urgent Hemodialysis Sessions Impacts and Outcome
Urgent Hemodialysis Sessions Impacts and Outcome Urgent Hemodialysis Sessions Impacts and Outcome
Urgent Hemodialysis Sessions Impacts and Outcome
 
Dialysis emergencies
Dialysis emergencies Dialysis emergencies
Dialysis emergencies
 
What is new in sepsis
What is new in sepsisWhat is new in sepsis
What is new in sepsis
 
Hemodialysis complications
Hemodialysis complicationsHemodialysis complications
Hemodialysis complications
 
Principle of iv fluid in septic shock
Principle of iv fluid in septic shockPrinciple of iv fluid in septic shock
Principle of iv fluid in septic shock
 
Dialyisis disequilibrium syndrome
Dialyisis disequilibrium syndromeDialyisis disequilibrium syndrome
Dialyisis disequilibrium syndrome
 

En vedette

Anatomy revision part 1
Anatomy revision part 1Anatomy revision part 1
Anatomy revision part 1
Ben Widaja
 
Mrcs Part A Experience
Mrcs Part A ExperienceMrcs Part A Experience
Mrcs Part A Experience
Kareem Hamimy
 

En vedette (13)

Femoral line
Femoral line Femoral line
Femoral line
 
MRCS preparation emrcs questions upperlimb
MRCS preparation emrcs questions upperlimbMRCS preparation emrcs questions upperlimb
MRCS preparation emrcs questions upperlimb
 
Anatomy revision part 1
Anatomy revision part 1Anatomy revision part 1
Anatomy revision part 1
 
MRCS preparation emrcs questions Lowerlimb
MRCS preparation emrcs questions Lowerlimb MRCS preparation emrcs questions Lowerlimb
MRCS preparation emrcs questions Lowerlimb
 
MRCS preparation emrcs questions Pathology
MRCS preparation emrcs questions PathologyMRCS preparation emrcs questions Pathology
MRCS preparation emrcs questions Pathology
 
Sepsis guidelines 2015
Sepsis guidelines 2015 Sepsis guidelines 2015
Sepsis guidelines 2015
 
MRCS Preparation emrcs questions Headneck
MRCS Preparation emrcs questions HeadneckMRCS Preparation emrcs questions Headneck
MRCS Preparation emrcs questions Headneck
 
Mrcs Part A Experience
Mrcs Part A ExperienceMrcs Part A Experience
Mrcs Part A Experience
 
MRCS preparation emrcs question Physiology
MRCS preparation emrcs question PhysiologyMRCS preparation emrcs question Physiology
MRCS preparation emrcs question Physiology
 
MRCS preparation eMrcs questions surgery
MRCS preparation eMrcs questions   surgeryMRCS preparation eMrcs questions   surgery
MRCS preparation eMrcs questions surgery
 
Anatomy upper limb mrcs part a
Anatomy upper limb mrcs part a Anatomy upper limb mrcs part a
Anatomy upper limb mrcs part a
 
Sepsis power point presentation
Sepsis power point presentationSepsis power point presentation
Sepsis power point presentation
 
New MRCS Part A Exam format
New MRCS Part A Exam formatNew MRCS Part A Exam format
New MRCS Part A Exam format
 

Similaire à Sepsis nuts&bolts

Sepsis in surgical patients and its biomarkers.pptx
Sepsis in surgical patients and its biomarkers.pptxSepsis in surgical patients and its biomarkers.pptx
Sepsis in surgical patients and its biomarkers.pptx
samrat277229
 
Patho Physiology And Icu Management Of Septic Shock
Patho Physiology And Icu Management Of Septic ShockPatho Physiology And Icu Management Of Septic Shock
Patho Physiology And Icu Management Of Septic Shock
chandra talur
 
Sepsis – pathophysiology and management
Sepsis – pathophysiology and managementSepsis – pathophysiology and management
Sepsis – pathophysiology and management
Vidhi Singh
 
23 Ppt Itp
23 Ppt Itp23 Ppt Itp
23 Ppt Itp
ghalan
 

Similaire à Sepsis nuts&bolts (20)

SEPSIS AND SEPTIC SHOCK.pptx
SEPSIS AND SEPTIC SHOCK.pptxSEPSIS AND SEPTIC SHOCK.pptx
SEPSIS AND SEPTIC SHOCK.pptx
 
Septic shock.pptx
Septic shock.pptxSeptic shock.pptx
Septic shock.pptx
 
Sepsis in surgical patients and its biomarkers.pptx
Sepsis in surgical patients and its biomarkers.pptxSepsis in surgical patients and its biomarkers.pptx
Sepsis in surgical patients and its biomarkers.pptx
 
Patho Physiology And Icu Management Of Septic Shock
Patho Physiology And Icu Management Of Septic ShockPatho Physiology And Icu Management Of Septic Shock
Patho Physiology And Icu Management Of Septic Shock
 
Role of autopsy in sepsis relatd death
Role of autopsy in sepsis relatd deathRole of autopsy in sepsis relatd death
Role of autopsy in sepsis relatd death
 
Goutham seminar
Goutham seminarGoutham seminar
Goutham seminar
 
Sepsis – pathophysiology and management
Sepsis – pathophysiology and managementSepsis – pathophysiology and management
Sepsis – pathophysiology and management
 
Sepsis lecture 2015 slide share
Sepsis lecture 2015 slide shareSepsis lecture 2015 slide share
Sepsis lecture 2015 slide share
 
Shock
ShockShock
Shock
 
Sepsis
SepsisSepsis
Sepsis
 
sepsis.pptx
sepsis.pptxsepsis.pptx
sepsis.pptx
 
Chapter 8
Chapter 8Chapter 8
Chapter 8
 
Mss
MssMss
Mss
 
23 Ppt Itp
23 Ppt Itp23 Ppt Itp
23 Ppt Itp
 
Fluid balance and therapy in critically ill
Fluid balance and therapy in critically illFluid balance and therapy in critically ill
Fluid balance and therapy in critically ill
 
Shock
ShockShock
Shock
 
Sepsis - Process and Scale - Daniels
Sepsis - Process and Scale - DanielsSepsis - Process and Scale - Daniels
Sepsis - Process and Scale - Daniels
 
SEPSIS MANGEMENT IN THE EMERGENCIES.pptx
SEPSIS MANGEMENT IN THE  EMERGENCIES.pptxSEPSIS MANGEMENT IN THE  EMERGENCIES.pptx
SEPSIS MANGEMENT IN THE EMERGENCIES.pptx
 
Obstetric shock.PDF
Obstetric shock.PDFObstetric shock.PDF
Obstetric shock.PDF
 
sepsis pharmacotherapy
sepsis pharmacotherapysepsis pharmacotherapy
sepsis pharmacotherapy
 

Plus de MEEQAT HOSPITAL

Plus de MEEQAT HOSPITAL (20)

Updated conscious sedation course.ppt
Updated conscious sedation course.pptUpdated conscious sedation course.ppt
Updated conscious sedation course.ppt
 
fatal asthma.pptx
fatal asthma.pptxfatal asthma.pptx
fatal asthma.pptx
 
Updated algorithm of ER – ICU - In - patients guidelines.pptx
Updated algorithm of ER – ICU -  In - patients guidelines.pptxUpdated algorithm of ER – ICU -  In - patients guidelines.pptx
Updated algorithm of ER – ICU - In - patients guidelines.pptx
 
Blood Bank Lecture .pptx
Blood Bank Lecture .pptxBlood Bank Lecture .pptx
Blood Bank Lecture .pptx
 
Post covid -19 syndrome
Post covid -19 syndromePost covid -19 syndrome
Post covid -19 syndrome
 
Sepsis and septic shock guidelines 2021. part 1
Sepsis and septic shock guidelines 2021. part 1Sepsis and septic shock guidelines 2021. part 1
Sepsis and septic shock guidelines 2021. part 1
 
Sepsis hemodynamic update part two
Sepsis hemodynamic update      part twoSepsis hemodynamic update      part two
Sepsis hemodynamic update part two
 
sepsis SSC 2021 Updates Ventilation and additional therapy
sepsis SSC 2021 Updates Ventilation and additional therapysepsis SSC 2021 Updates Ventilation and additional therapy
sepsis SSC 2021 Updates Ventilation and additional therapy
 
Sepsis scoring
Sepsis  scoringSepsis  scoring
Sepsis scoring
 
Surviving sepsis compaign (adults) Guidelines updates 2021. “Long Term Outcom...
Surviving sepsis compaign (adults)Guidelines updates 2021.“Long Term Outcom...Surviving sepsis compaign (adults)Guidelines updates 2021.“Long Term Outcom...
Surviving sepsis compaign (adults) Guidelines updates 2021. “Long Term Outcom...
 
Medication error, nursing responsibility
Medication error, nursing responsibilityMedication error, nursing responsibility
Medication error, nursing responsibility
 
Deep venous thrombosis dvt
Deep venous thrombosis dvtDeep venous thrombosis dvt
Deep venous thrombosis dvt
 
Bed sore management
Bed sore managementBed sore management
Bed sore management
 
Chest intubation indications,precautions and management
Chest intubation indications,precautions and managementChest intubation indications,precautions and management
Chest intubation indications,precautions and management
 
Portable ventilator
Portable ventilatorPortable ventilator
Portable ventilator
 
Covid19 corona management -كوفيد19
Covid19 corona management -كوفيد19Covid19 corona management -كوفيد19
Covid19 corona management -كوفيد19
 
Sedation
SedationSedation
Sedation
 
Conscious sedation course
Conscious sedation courseConscious sedation course
Conscious sedation course
 
Electronic medica file
Electronic medica fileElectronic medica file
Electronic medica file
 
Medical permission for patient
Medical permission for patientMedical permission for patient
Medical permission for patient
 

Dernier

Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
ZurliaSoop
 

Dernier (20)

Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 
Single or Multiple melodic lines structure
Single or Multiple melodic lines structureSingle or Multiple melodic lines structure
Single or Multiple melodic lines structure
 
Dyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptxDyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptx
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - English
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024
 
Fostering Friendships - Enhancing Social Bonds in the Classroom
Fostering Friendships - Enhancing Social Bonds  in the ClassroomFostering Friendships - Enhancing Social Bonds  in the Classroom
Fostering Friendships - Enhancing Social Bonds in the Classroom
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
SOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning PresentationSOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning Presentation
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701
 
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
 

Sepsis nuts&bolts

  • 1. Dr.shenawi Cons. general surgery M.g.h MBBCh,MsC,MrCs(irelanD)
  • 2.  I,m not an intensivist &apologize for deficiency it might encountered on the mini lecture.  Thanks& greeting to all my colleagues& staff in MGH,for their sympathy and support given to me during my assignment in hajj duty.  Accept my appology for any missbehave might happen from me during my duty. Dr.abdulfattah alshenawi
  • 3.  It’s common and increasing in frequency as the population ages  It’s associated with high risk of death and long length of stay We could make a  It’s expensive difference  AND…. The good new is:  There are interventions proven to reduce mortality & cost.  However implementation of these interventions are not routinely done in all hospitals!!
  • 4.  35% diagnosed in hospital wards.  52% diagnosed in ED.  13 % diagnosed in ICU.  Hospitalization for sepsis & sepsis related illness has doubled in the states from year 2000 -2008.
  • 5.  Sever sepsis & septic shock is the leading cause of death in the non coronary care with mortality rate of 20 -50%. Ischemic stroke 1-2% STEMI 3-5%
  • 6. Cost 14-18 billion USD /y. Cost 18.000 USD/case.
  • 7.
  • 8.  Inflammation is a war!  Non specific localized tissue response to injury.  Purpose: ◦ Destroy ◦ Dilute ◦ Dam-off  result is healing ◦ Regeneration (hyperplasia) ◦ Fibrosis (scarring)  Collateral damage may occur(SIRS)
  • 9.  1. Stimulus: Initiators of inflammation  2. Local dilation of capillaries: increased blood flow  3. Microvascular structural changes: escape of  plasma proteins from bloodstream  4. Leukocyte transmigration through endothelium  and accumulation at injury site  5. Phagocytosis / Oxygen burst: Cellular injury
  • 10.
  • 11.  Leucocytic response.(organism specific)  Margination&migration of neutrophils(90min)  Phagocytosis .(physiologic debridment)  Monocyte migration(24hrs)-macrophage.  Release of cytokines.
  • 12. Definition: Any messenger that acts on blood vessels, inflammatory cells, or other cells to contribute to an inflammatory response. (Pretty much anything...)
  • 13.  Plasma proteins such as complement and antibodies.  Other proteins such as sPLA2 and acute phase reactants.  Cytokines and chemokines.  Lipids such as prostaglandins and PAF.  Amines such as histamine.  ‘Gasses’ such as NO and O2-.  Kinins such as bradykinin.  Neuropeptides such as substance P.
  • 14.  Systemic absorption of locally generated inflamatory mediators.  Non specific response!!!  May be due to infectious or non infectious causes.
  • 15.  Fever>100  pulse.>100  SBP<100  leucocytosis  RR>20 May be caused by infections(sepsis)  Altered mental status  Hyperglycemia  or non infections(burn,trauma,pancreatitis, ischemia,reperfusion,chemical)
  • 16.
  • 17. SIRS SEPSIS SEVER SEPSIS SEPTIC SHOCK
  • 18. SIRS+INFECTION(kn own or suspected) Infection may be bacterial,viral ,fungal … etc.
  • 19. TRAUMA BURNS INFECTION SSEEPPSSIISS SIRS PANCREAITIS BACTEREMIA
  • 21.  SEVER SEPSIS+ REFRACTORY HYPOTENSION
  • 22.  Normal response to infection. Recognition of foreign antigen. Immune system release inflammatory mediators(PG,TNF,cytokines,interleuk) Platlet activating factors. Promote recovery of the affected tissues.
  • 23.  Uncontrolled response to infection(sepsis syn)  Flood of inflammatory mediators Capillary leak.  Activation of clotting cascade.  Tissue hypoxia & hypoperfusion.  Septic shock. Microcirculatory failure is the key!!!
  • 24. Figure B, page 948, reproduced with permission from Dellinger RP. Cardiovascular management of septic shock. Crit Care Med 2003;31:946-955.
  • 25.  Site of oxygen exchange. Central role of the immune system. During septic shock,it the first to go & late to recover. Rescue microcirculation is the resuscitation end point.
  • 26. Infection Inflammatory Mediators Endothelial Vasodilation Dysfunction Hypotension Microvascular Plugging Vasoconstriction Edema Maldistribution of Microvascular Blood Flow Ischemia Cell Death Organ Dysfunction
  • 27. Oxygen won,t go where blood don,t flow. Early goal directed therapy(EGDT) IS to restore microcirculation before mitochondia is permenantly damaged.
  • 28. Acute organ dysfunction is the marker of sever sepsis. One organ damage lead to 20% increase mortality& double thereafter.
  • 29. A clinician, armed with the sepsis bundles, attacks the three heads of severe sepsis: hypotension, hypoperfusion and organ dysfunction .
  • 30.  Recognition& screening for sepsis.  ivf  Early antibiotics.  Transfer trigger tool.  Emergency dept. initiation of 6hs bundle.
  • 31.  Non specific symptoms in elderly pt.  Fever may be absent.13% in pt>65y& 4% in pt<65y  Tachycardia may be absent.  Presentation may be of M.O.D initially.
  • 32. Pt. presented with. Weakness Confusion Vomiting Syncope early recognition of sepsis & implementation of evidence based tools improves outcome & reduce mortality.
  • 33.  Sepsis screening tools should be practiced in all hospitals& wards(ER,ICU,& GENERAL WARDS)
  • 34. 2 or more of the following  Temp>100 F  Pulse>100/min  SBP<100mmHg. RR>20/min  Spo2<90%  Altered LOC
  • 35.  Initiate evaluation for sever sepsis & septic shock.  Order S. lactate(result within 30min)  Order CBC,ABG,U/cr/E,& metabolic profile.  Attach monitors.  Start IVF & antibiotics.  Notify consultant.
  • 36.  Lactate is a surrogate marker of global tissue hypoxia.  Normal is<2mmol/l  More >4mmol/l indicate tissue hypoperfusion  Lactate elevation above normal associated with increased mortality.  Marker of (OCCULT )sepsis before hypoperfusion or altered LOC happen.
  • 37.  Arterial or venous, no tourniquet  Normal lactate do not rule out severe sepsis.  Lactate may be elevated with seizures, liver cell failure, ischemic bowels,& drugs
  • 38.  Decrease by> 10% every hour.  Normalisation within 6 hs. Associated with reduced mortality.  Half life of lactate is 20 min.
  • 39.
  • 40. 20 -30 ml /kg initial fluid bolus. Minimum 1 L bolus. Minimum of 30ml/kg in the first 3hrs.
  • 41.  Each 1 h delay in effective antibiotics is associated with decrease in survival by 7.6%.  Triage time to appropriate antibiotics<1hr _____mortality 19.5 vs 32.2%
  • 42. Don,t let a prolonged search for the source delay antibiotic administration. Brief search &best guess ABX. consider blood culture & empiric antibiotics pending further evaluation Stop antibiotics when no longer needed.
  • 43.  Follow your own hospital protocol.  Pipracillin / tazocin. 4.5gm/6h.+  Vancomycin 2gm iv stat then adjust according to pharmacy.  Penicillin allergy  meropenem 1gm iv/8h  Community acquired pneumonia  Levofloxacin 750mg iv/24h  Azithromycin 500mgiv/24h
  • 44.  For hospital without ICU. any of the following PROGRESSIVE SYMPTOMS DESPITE TREATMENT PERSISTENT ELEVATED LACT.>4mmol/l PERSISTENT HYPOTENSION DESPITE FLUID CHALLENGE MORE THAN TWO ORGAN DYSFUNCTION
  • 45.  To be completed within 3 hs!! Measure lactate. Bl. Culture prior to antibiotics. Antibiotics.  Infusion of 30ml/kg crystalloids in hypotension or lactate >4mmol/l
  • 46.  Apply vasopressors for those not responding to fluid challenge to maintain MAP>65 mmhg.  Persistent hypotension despit fluids, measure CVP ScvO2  Re measure lactate if initially elevated.
  • 47.
  • 48. 1. CVP of 10mmhg for unventilated &12-15 mmhg for the ventilated 2. MAP >65mmhg 3. Hemoglobin > 9 gm/dL 4. ScvO2 > 70% 5. UOP>0.5ml/h
  • 49.
  • 50. 3 hs bundle  (culture, crystalloid, lactate,& antibiotic.) 6 hs bundle Continue resuscitation Cvp,monitor,follow lactate. Consider inotropes
  • 51.  Screen pt . For sepsis. In ED &wards.  Evaluate all pt. with sepsis for organ dysfunction to identify sever sepsis.  Implement sepsis bundles for all pts with sever sepsis & septic shock.
  • 52.  Obtain lactate when 2 SIRS or suspected infection.  Begin 3hrs bundle when screen is +ve.  For ED pt. u have 3 hrs from arrival to determine pt has an infection, find the likely source,& begin the appropriate therapy.  Clock is not your friend!